Gallo, A.; MacDonald, T.; Bennett, K.; Basso-Hulse, G.; Hulse, G.
Is the Precipitation of Anxiety Symptoms Associated with Bolus Doses of Flumazenil a Barrier to Its Use at Low Continuous Doses in Benzodiazepine Withdrawal? J. Clin. Med. 2022, 11, 5948.
https://doi.org/10.3390/jcm11195948
AMA Style
Gallo A, MacDonald T, Bennett K, Basso-Hulse G, Hulse G.
Is the Precipitation of Anxiety Symptoms Associated with Bolus Doses of Flumazenil a Barrier to Its Use at Low Continuous Doses in Benzodiazepine Withdrawal? Journal of Clinical Medicine. 2022; 11(19):5948.
https://doi.org/10.3390/jcm11195948
Chicago/Turabian Style
Gallo, Alexander, Tim MacDonald, Kellie Bennett, Gioiamia Basso-Hulse, and Gary Hulse.
2022. "Is the Precipitation of Anxiety Symptoms Associated with Bolus Doses of Flumazenil a Barrier to Its Use at Low Continuous Doses in Benzodiazepine Withdrawal?" Journal of Clinical Medicine 11, no. 19: 5948.
https://doi.org/10.3390/jcm11195948
APA Style
Gallo, A., MacDonald, T., Bennett, K., Basso-Hulse, G., & Hulse, G.
(2022). Is the Precipitation of Anxiety Symptoms Associated with Bolus Doses of Flumazenil a Barrier to Its Use at Low Continuous Doses in Benzodiazepine Withdrawal? Journal of Clinical Medicine, 11(19), 5948.
https://doi.org/10.3390/jcm11195948